ASCO 2013: PET scan illuminates breast cancer’s weaknesses (VIDEO)
Monday, June 3, 2013
Trastuzumab (also known as Herceptin) and other breast cancer treatments targeting the HER2 protein have saved numerous lives, but the therapy doesn’t benefit all patients equally.
Further, because treatments are expensive — Herceptin for a year costs approximately $54,000 — and come with serious side effects, clinicians are looking for ways to identify breast cancers that are most likely to respond to the drug.
The answer may lie in positron emission tomography (PET) scans, according to City of Hope research being presented at the American Society of Clinical Oncology annual meeting in Chicago.
City of Hope combines compassionate care with the best and most innovative science. Our 100+ acre campus is designed to meet the full range of needs of our patients and families. This guide is designed to help you take advantage of all that is offered at City of Hope.
City of Hope’s Physician’s Bulletin is a publication for healthcare professionals that provides news and information about current research activities and significant trends in cancer treatment options.
Phone: (800) 826-HOPE (4673)
Hours: M – F, 8 a.m. to 5 p.m. (PST)
Calls received after 5 p.m. will be returned the next business day.